Our expertise in biopharma
and biotech investments
With decades of experience and a robust network within the biopharma and biotech industries, our team offers unparalleled insight into the scientific and financial landscapes. We are dedicated to identifying transformative therapies and supporting companies that are pioneering the future of healthcare.
Life Sciences Background
Our deep understanding of scientific principles combined with our commitment to improving patients outcomes enable us to accelerate the translation of cutting-edge research.
Multidisciplinary Team
With backgrounds spanning PhDs, MDs and accomplished inventors educated at prestigious institutions like Harvard, MIT, and Imperial College, we offer a unique blend of scientific expertise business acumen.
Empowering entrepeneurs to build leading companies
Biovance Capital works closely with entrepreneurs to build leading companies with transformative treatments for patients in need.
Stage
We invest in early-stage companies at seed and Series A rounds across Europe, with a focus in Southern countries.
Technology
We invest in biotech companies developing therapeutics in any modality and therapeutic area. We require robust and appropriate preclinical models and patented or patentable assets before investing.
Market
Large target market with a clear regulatory pathway for approval, with favorable reimbursement and pricing policies.
Exit Potential
Sectors with VC/M&A or IPO activity, featuring profitable exits and multiple potential acquirers.
Sustainability
During the due diligence process, sustainability risks are taken into account, and whenever identified, mitigation measures are proposed.
Our Partners
Instituto de Investigação
e Inovação em Saúde
Startup Research Nova
Tec Labs
Eit Health
Universidade de Coimbra
Co-Lab AccelBio
Atlas Metrics
